Search for: "Pharmaceutical Generic Developers, Inc."
Results 1 - 20
of 1,119
Sorted by Relevance
|
Sort by Date
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
14 Feb 2017, 9:13 pm
The lawsuit involved Watson's ANDA filing seeking approval for a generic version of Shire's controlled-release oral pharmaceutical composition for the treatment of inflammatory bowel disease, Crohn's disease, and ulcerative colitis, sold by Shire under the brand name LIALDA®. [read post]
14 Oct 2011, 6:10 pm
Orange County - Noven Pharmaceuticals, Inc. has filed an action for patent infringement against Watson Pharmaceuticals, Inc. in a federal district court in New Jersey. [read post]
15 Feb 2017, 2:49 pm
Watson Pharmaceuticals, Inc., February 10, 2017, Hughes, T.). [read post]
5 Oct 2009, 9:00 am
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. [read post]
15 Aug 2015, 1:03 pm
Wyeth Pharmaceuticals, Inc., was filed in the U.S. [read post]
6 Oct 2021, 10:12 am
Generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, will pay $447.2 million to settle allegations that they conspired to artificially inflate the price of multiple generic drugs. [read post]
3 Dec 2008, 11:18 pm
By Sherri Oslick -- Earlier this week, Impax Laboratories, Inc. and Medicis Pharmaceutical Corp. announced that they have entered a Joint Development Agreement and a Settlement and License Agreement that brings to an end their pending lawsuit over Impax's plans to manufacture a generic version of Medics' Solodyn ® (minocycline hydrochloride extended release tablets, used to treat acne). [read post]
13 Jan 2012, 7:41 am
In that case, SigmaPharm alleged that the King-Mutual agreement eliminated sales of a generic version of Skelaxin to the detriment of SigmaPharm, which had a development agreement with Mutual. [read post]
12 May 2010, 5:49 pm
The members of the Creditors' Committee are: Par Pharmaceutical, Inc. [read post]
18 Oct 2008, 8:19 am
In the Hatch-Waxman area, Pozen, Inc. announced Par Pharmaceutical Inc. has filed an application with the Food and Drug Administration [FDA] to make a generic version of Treximet, a migraine treatment Pozen developed with GlaxoSmithKline PLC, and shares of Pozen shed nearly 28 percent of their value on 17 Oct. 08 [read post]
4 Nov 2009, 9:28 pm
On Nov. 2, King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., and Gentrac, Inc., filed suit against Seattle-based ZymoGenetics, Inc., in the Eastern District of Tennessee. [read post]
13 Mar 2013, 4:45 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
7 Jan 2022, 12:56 pm
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
7 Jan 2022, 12:56 pm
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
3 May 2011, 7:16 am
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
25 Mar 2007, 9:19 pm
Following a successful patent defense on Zyprexa, Lilly now faces challenges to Gemzar (gemcitabine, an injectible chemotherapy that treats several forms of cancer) from Sicor Pharmaceuticals Inc., Mayne Pharma Inc. and Sun Pharmaceutical Industries Inc. through challenges mounted via provisions of the Hatch-Waxman Act. [read post]
28 Jan 2016, 6:03 am
In October 2015, press reports began appearing suggesting that Pfizer Inc., one of the world’s largest pharmaceutical companies, and Allergan, an Irish publicly traded pharmaceutical company, were considering entering into the largest inversion in history. [read post]
28 Feb 2011, 8:27 pm
Pharmaceutical Product Development, Inc. v. [read post]
